title: Outcome analysis of FK 506 therapy for acute and chronic rejection.
authors.affiliation: Department of Surgery, Baylor University Medical Center, Dallas, Texas 75246.
authors.forename: J F
authors.initials: JF
authors.lastname: Gibbs
authors.forename: B S
authors.initials: BS
authors.lastname: Husberg
authors.forename: G B
authors.initials: GB
authors.lastname: Klintmalm
authors.forename: L
authors.initials: L
authors.lastname: Backman
authors.forename: M
authors.initials: M
authors.lastname: Levy
authors.forename: R
authors.initials: R
authors.lastname: McMillan
authors.forename: R M
authors.initials: RM
authors.lastname: Goldstein
authors.forename: M J
authors.initials: MJ
authors.lastname: Holman
authors.forename: T A
authors.initials: TA
authors.lastname: Gonwa
authors.forename: C
authors.initials: C
authors.lastname: Morris
mesh_terms: D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus